Buy, Sell or Hold: incyte (INCY-Q)

Home

Daily Stock Opinions and Ratings

incyte (INCY-Q)

84.73

-1.80 (2.08%)

as of Sep 22, 2025, 8:00:00 pm Market Open.

0 watching

Nervous markets await Nvidia

Most recent Opinions go here

Be up to date, don’t miss your chance.

BUY

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.

DON'T BUY

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.

Showing 1 to 2 of 2 entries

incyte(INCY-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for incyte is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

incyte(INCY-Q) Frequently Asked Questions

What is incyte stock symbol?

incyte is a American stock, trading under the symbol INCY-Q on the NASDAQ (INCY). It is usually referred to as NASDAQ:INCY or INCY-Q

Is incyte a buy or a sell?

In the last year, 2 stock analysts published opinions about INCY-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for incyte.

Is incyte a good investment or a top pick?

incyte was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for incyte.

Why is incyte stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is incyte worth watching?

In the last year 2 stock analysts on Stockchase covered incyte. The stock is worth watching.

What is incyte stock price?

On 2025-09-22, incyte (INCY-Q) stock closed at a price of $84.73.

Most Recent Experts

Brendan Caldwell

Caldwell Securities

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Peter Hodson

5i Research Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.